Arbutus Biopharma Corp (ABUS) Shock: Unpacking Today’s Price Drop
Jefferies has recently raised Arbutus Biopharma Corp (ABUS) stock to Buy rating, as announced on February 2, 2022, according to Finviz. Earlier, on February 25, 2021, Jefferies had initiated the stock to Hold, setting a price target of $5. H.C. Wainwright also initiated Buy rating with a price target of $10. Additionally, JMP Securities resumed […]
ABUS’s Latest Twist: What’s Fueling the Unexpected Shifts in Arbutus Biopharma Corp’s Stock Price?
Jefferies has recently raised Arbutus Biopharma Corp (ABUS) stock to Buy rating, as announced on February 2, 2022, according to Finviz. Earlier, on February 25, 2021, Jefferies had initiated the stock to Hold, setting a price target of $5. H.C. Wainwright also initiated Buy rating with a price target of $10. Additionally, JMP Securities resumed […]
The Arbutus Biopharma Corp Enigma: What’s Causing the Wild Swings in ABUS Stock?
Jefferies has recently raised Arbutus Biopharma Corp (ABUS) stock to Buy rating, as announced on February 2, 2022, according to Finviz. Earlier, on February 25, 2021, Jefferies had initiated the stock to Hold, setting a price target of $5. H.C. Wainwright also initiated Buy rating with a price target of $10. Additionally, JMP Securities resumed […]
Arbutus Biopharma Corp (ABUS) Stock: Greater Than Its Current Valuation?
Jefferies has recently raised Arbutus Biopharma Corp (ABUS) stock to Buy rating, as announced on February 2, 2022, according to Finviz. Earlier, on February 25, 2021, Jefferies had initiated the stock to Hold, setting a price target of $5. H.C. Wainwright also initiated Buy rating with a price target of $10. Additionally, JMP Securities resumed […]
Arbutus Biopharma Corp (ABUS) Stock: More Robust Than the Numbers Suggest?
Jefferies has recently raised Arbutus Biopharma Corp (ABUS) stock to Buy rating, as announced on February 2, 2022, according to Finviz. Earlier, on February 25, 2021, Jefferies had initiated the stock to Hold, setting a price target of $5. H.C. Wainwright also initiated Buy rating with a price target of $10. Additionally, JMP Securities resumed […]
Arbutus Biopharma Corp (ABUS) Stock: Greater Than Its Current Valuation?
Jefferies has recently raised Arbutus Biopharma Corp (ABUS) stock to Buy rating, as announced on February 2, 2022, according to Finviz. Earlier, on February 25, 2021, Jefferies had initiated the stock to Hold, setting a price target of $5. H.C. Wainwright also initiated Buy rating with a price target of $10. Additionally, JMP Securities resumed […]
Arbutus Biopharma Corp (ABUS) Stock: More Robust Than the Numbers Suggest?
Jefferies has recently raised Arbutus Biopharma Corp (ABUS) stock to Buy rating, as announced on February 2, 2022, according to Finviz. Earlier, on February 25, 2021, Jefferies had initiated the stock to Hold, setting a price target of $5. H.C. Wainwright also initiated Buy rating with a price target of $10. Additionally, JMP Securities resumed […]
Why Did Arbutus Biopharma Corp (ABUS) Stock Plunge -5.16% Last Week?
Jefferies has recently raised Arbutus Biopharma Corp (ABUS) stock to Buy rating, as announced on February 2, 2022, according to Finviz. Earlier, on February 25, 2021, Jefferies had initiated the stock to Hold, setting a price target of $5. H.C. Wainwright also initiated Buy rating with a price target of $10. Additionally, JMP Securities resumed […]
Arbutus Biopharma Corp (ABUS) Stock: Beyond the Surface of Its Performance?
Jefferies has recently raised Arbutus Biopharma Corp (ABUS) stock to Buy rating, as announced on February 2, 2022, according to Finviz. Earlier, on February 25, 2021, Jefferies had initiated the stock to Hold, setting a price target of $5. H.C. Wainwright also initiated Buy rating with a price target of $10. Additionally, JMP Securities resumed […]
Why Is Arbutus Biopharma Corp (ABUS) Stock Surpassing 17.31% from Its 50-Day SMA?
Jefferies has recently raised Arbutus Biopharma Corp (ABUS) stock to Buy rating, as announced on February 2, 2022, according to Finviz. Earlier, on February 25, 2021, Jefferies had initiated the stock to Hold, setting a price target of $5. H.C. Wainwright also initiated Buy rating with a price target of $10. Additionally, JMP Securities resumed […]
